Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.60 TWD
−682.85 M TWD
652.62 M TWD
171.67 M
About MYCENAX BIOTECH INC.
Sector
Industry
CEO
Pei Chun Chen
Website
Headquarters
Miaoli
Founded
2001
ISIN
TW0004726005
FIGI
BBG000JVX7J8
Mycenax Biotech, Inc. engages in the research and development, manufacture, and sale of biopharmaceutical products. It offers new protein molecules and biosmilars. It provides contract development and manufacturing organization services including cell line development, process development, analytics and quality control, good manufacturing practice, aseptic fill and finish, and regulatory compliance services. The company was founded by Ching Ying Chen, Ching Chu Feng and Yi Hsu Huang on September 28, 2001 and is headquartered in Miaoli, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4726 is 43.75 TWD — it has increased by 0.12% in the past 24 hours. Watch MYCENAX BIOTECH INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange MYCENAX BIOTECH INC. stocks are traded under the ticker 4726.
4726 stock has fallen by −3.33% compared to the previous week, the month change is a −8.49% fall, over the last year MYCENAX BIOTECH INC. has showed a 24.29% increase.
4726 reached its all-time high on Oct 8, 2013 with the price of 114.20 TWD, and its all-time low was 12.35 TWD and was reached on Nov 24, 2011. View more price dynamics on 4726 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4726 stock is 5.28% volatile and has beta coefficient of 0.14. Track MYCENAX BIOTECH INC. stock price on the chart and check out the list of the most volatile stocks — is MYCENAX BIOTECH INC. there?
Today MYCENAX BIOTECH INC. has the market capitalization of 8.69 B, it has decreased by −1.85% over the last week.
Yes, you can track MYCENAX BIOTECH INC. financials in yearly and quarterly reports right on TradingView.
MYCENAX BIOTECH INC. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
4726 net income for the last quarter is −146.61 M TWD, while the quarter before that showed −101.62 M TWD of net income which accounts for −44.28% change. Track more MYCENAX BIOTECH INC. financial stats to get the full picture.
No, 4726 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 304.00 employees. See our rating of the largest employees — is MYCENAX BIOTECH INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MYCENAX BIOTECH INC. EBITDA is −185.62 M TWD, and current EBITDA margin is −44.03%. See more stats in MYCENAX BIOTECH INC. financial statements.
Like other stocks, 4726 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYCENAX BIOTECH INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYCENAX BIOTECH INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYCENAX BIOTECH INC. stock shows the neutral signal. See more of MYCENAX BIOTECH INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.